Intrinsiqq
LadRx Corporation logo

LadRx Corporation Financials

LADX

Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 5 of 16 available years
Income Statement
DEC 2024
DEC 2023
DEC 2022
DEC 2021
DEC 2020
General & Administrative$3$4$5$6$6
Research & Development$1$0––$1
Total Operating Expenses$4$4$5$12$7
Operating Income-$4-$4-$5-$12-$7
Non-Operating
Net Interest Expense––––$0
Other Non-Operating Income (Expense)–$0-$0-$0$0
EBT (Earnings Before Tax)–––-$13-$7
Income Tax Expense––––$0
Earnings from Continuing Ops––––-$7
Net Income
Net Income-$2$0-$4-$13-$7
EPS (Basic)-$3.21$0.68-$0.11-$0.35-$0.19
EPS (Diluted)-$3.21$0.68-$0.11-$0.35-$0.19
Weighted Avg Shares (Basic)495,092488,39243.4M37.6M34.7M
Weighted Avg Shares (Diluted)495,092488,392450,37437.6M34.7M
Shares Outstanding495,092488,392450,37437.6M34.7M

LadRx (LADX) financials: revenue, profit and margins

LadRx (LADX) generated about n/a in revenue and -$2 million in net income over the trailing twelve months, growing at roughly -59.7% a year. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is LadRx profitable?+

LadRx reported about -$2 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How fast is LadRx growing?+

LadRx's revenue has compounded at roughly -59.7% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside LADX's margins and free cash flow. This is analysis from SEC filings, not investment advice.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 14 May 2025, covering the period ending 31 Mar 2025, as reported to the SEC. Data last refreshed 21 Aug 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with LADX

CompareIntrinsic value
OTLKOutlook Therapeutics Inc.
$0.39-3.32%10
SCLXScilex Holding Company
$0.57-12.95%0
ELUTElutia Inc.
$0.89+8.54%20
CRISCuris Inc.
$0.44-7.21%35
INBXInhibrx Biosciences, Inc.
$68.97-7.21%18
CRBUCaribou Biosciences, Inc.
$0.28-8.59%10
ACOGAlpha Cognition Inc.
$9.00+1.69%10
MGTXMeiraGTx Holdings plc
$7.98-1.97%60

Spot a number that looks wrong? Check it in LADX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing LADX

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.